Correlation analysis of serum soluble tumor necrosis factor-related apoptosis-inducing ligand, galectin-3, nesfatin-1, and chronic obstructive pulmonary disease complicated with depression
ZHANG Changhong ZHANG Zhihua JI Zexuan
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China
Abstract Objective To investigate the correlation of serum soluble tumor necrosis factor-associated apoptosis-inducing ligand (sTRAIL), galectin-3, nesfatin-1 with chronic obstructive pulmonary disease (COPD) complicated with depression. Methods A total of 173 hospitalized patients with acute exacerbation of COPD admitted to the First Affiliated Hospital of Hebei North University from July 2019 to May 2021 were selected, including 103 patients in the simple COPD group and 70 patients in the COPD combined with depression group. Clinical data and serum levels of sTRAIL, galectin-3, and nesfatin-1 of the two groups were recorded and compared. Logistic regression model was used to analyze the influencing factors of COPD combined with depression, and receiver operating characteristic (ROC) curve was further drawn to evaluate the prediction efficiency. Results The COPD assessment test score, the proportion of poor treatment compliance, the proportion of chronic diseases, the proportion of patients living alone, and the serum levels of sTRAIL, galectin-3, and nesfatin-1 in the COPD combined with depression group were higher than those in the simple COPD group, the percentage of forced expiratory volume in first second to forced vital capacity (FEV1/FVC), the percentage of forced expiratory volume in the first second to the expected value (FEV1pred), and the proportion of employees medical insurance in the COPD combined with depression group were lower than those in the simple COPD group, and the differences were statistically significant (P＜0.05). The results of multivariate analysis showed that FEV1/FVC, FEV1pred, treatment compliance, medical insurance type, and serum sTRAIL, galectin-3, and nesfatin-1 were the influencing factors of COPD combined with depression (P＜0.05). ROC curve analysis showed that serum sTRAIL, galectin-3, and nesfatin-1 alone and in combination had certain predictive value for COPD complicated with depression (P＜0.05). Conclusion Depression in patients with COPD is associated with a variety of factors, serum sTRAIL, galectin-3, and nesfatin-1 joint detection merge depression in patients with COPD diagnosis has a certain value.
[1] Ritchie AI，Martinez FJ. The Challenges of Defining Early Chronic Obstructive Pulmonary Disease in the General Population [J]. Am J Respir Crit Care Med，2021，203（10）：1209-1210. [2] Wang C，Xu J，Yang L，et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China（the China Pulmonary Health[CPH]study）：a national cross-sectional study [J]. Lancet，2018，391（10131）：1706-1717. [3] Recio Iglesias J，Díez-Manglano J，López García F，et al. Management of the COPD Patient with Comorbidities：An Experts Recommendation Document [J]. In J Chron Obstruct Pulmton Dis，2020，15：1015-1037. [4] Beurel E，Toups M，Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation：Double Trouble [J]. Neuron，2020，107（2）：234-256. [5] Weiss JR，Serdenes R，Madtha U，et al. Association Among Chronic Obstructive Pulmonary Disease Severity，Exacerbation Risk，and Anxiety and Depression Symptoms in the SPIROMICS Cohort [J]. J Acad Consult Liaison Psychiatry，2023，64（1）：45-57. [6] Zaigham S，Dencker M，Karlsson MK，et al. Lung function is associated with tumour necrosis factor-related apoptosis-inducing ligand（TRAIL）levels in school-aged children [J]. Respir Med，2021，176：106235. [7] Sundqvist M，Andelid K，Ekberg-Jansson A，et al. Systemic Galectin-3 in Smokers with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis：The Impact of Exacerbations [J]. Int J Chron Obstruct Pulmon Dis，2021，16：367- 377. [8] Luo JJ，Wen FJ，Qiu D，et al. Nesfatin-1 in lipid metabolism and lipid-related diseases [J]. Clin Chim Acta，2021，522：23- 30. [9] Mirza S，Clay RD，Koslow MA，et al. COPD gvidelines：A review of the 2018 GOLD report [J]. Mayo Clin Proc，2018，93（10）：1488-1502. [10] Ardelean DL，Iulia L，Popescu R，et al. Evaluation of COPD patients using CAT-COPD assessment test [J]. Pneumologia，2012，61（4）：221-229. [11] Hamilton GA. Measuring adherence in a hypertension clinical trial [J]. Eur J Cardiovasc Nurs，2003，2（3）：219-228. [12] Xu WH，Wang Q，Liang WX. Reliability and validity of Morisky Questionnaire in measurement of the compliance with hypertensive medications [J]. Chin J Prev Contr Chron Noncommun Dis，2007，15（5）：424-426. [13] 汪向东，王希林，马弘.心理卫生评定量表手册（增订版）[M].北京：中国心理卫生杂志社，1999：33-37，174- 176，211-221. [14] 晏妮，董俊康，张明周，等.焦虑抑郁对慢性阻塞性肺疾病患者生活质量的影响及药物依从性中介作用[J].中华肺部疾病杂志（电子版），2022，15（6）：771-775. [15] 留永健，田欣伦，郭兮恒，等.慢性阻塞性肺疾病合并焦虑抑郁患病调查[J].中国呼吸与危重监护杂志，2020， 19（5）：425-429. [16] 杨琬芳，王青，杨智超，等.炎症驱动抑郁症发生发展的机制研究进展[J/OL].江苏大学学报（医学版）：1-9[2023- 03-22].https://doi.org/10.13312/j.issn.1671-7783.y230019. [17] Braithwaite AT，Marriott HM，Lawrie A. Divergent Roles for TRAIL in Lung Diseases [J]. Front Med（Lausanne），2018， 5：212. [18] Klaus F，Guetter K，Schlegel R，et al. Common and disorder-specific upregulation of the inflammatory markers TR- AIL and CCL20 in depression and schizophrenia [J]. Sci Rep，2021，11（1）：19204. [19] Wu Y，Shen Y，Zhang J，et al. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients [J]. Int J Chron Obstruct Pulmon Dis，2015，10：2405-2412. [20] Ajala O，Zhang Y，Gupta A，et al. Decreased serum TRAIL is associated with increased mortality in smokers with comorbid emphysema and coronary artery disease [J]. Respir Med，2018，145：21-27. [21] Mammen MJ，Ali J，Aurora A，et al. IL-17 Is a Key Regulator of Mucin-Galectin-3 Interactions in Asthma [J]. Int J Cell Biol，2021，2021：9997625. [22] Kartal Baykan E，■ebin E，Kara?鬤ahin ■，et al. Galectin-3：can it be a diagnostic tool for pneumonia in covid-19 patients？[J]. Turk J Med Sci，2021，51（5）：2256-2262. [23] 毛建华，王慧芬，杨利萍.半乳糖凝集素3在慢性阻塞性肺疾病患者中的水平变化及意义[J].中国卫生检验杂志，2020，30（22）：2768-2770，2773. [24] King DR，Salako DC，Arthur-Bentil SK，et al. Relationship between novel inflammatory biomarker galectin-3 and depression symptom severity in a large community-based sample [J]. J Affect Disord，2021，281：384-389. [25] 甘宇涛，尹祖斌，胡淯清，等.抑郁症患者血清Galectin-3、Netrin-1、IL-33水平与其认知功能损害的关系[J].标记免疫分析与临床，2021，28（4）：617-621. [26] 蔡文灿，李彤，刘彦明，等.阻塞性睡眠呼吸暂停综合征患者血清Nesfatin-1水平变化及临床意义[J].中国医药导报，2019，16（28）：162-165. [27] 刘亚男，何宁，勾璇.2型糖尿病合并阻塞性睡眠呼吸暂停低通气综合征患者血清Chemerin、Nesfatin-1、Obestatin的检测水平及意义[J].临床和实验医学杂志，2021，20（24）：2614-2617. [28] Leivo-Korpela S，Lehtim?ki L，H?m?lainen M，et al. Adipok- ines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease [J]. Mediators Inflamm，2014，2014：232167. [29] Shen X，Du X，Jiang H. Plasma levels of nesfatin-1 as a new biomarker in depression in Asians：evidence from meta- analysis [J]. Biomarkers，2020，25（3）：228-234.
